ABSTRACT
Introduction@#The World Association of Medical Education organizes medical education and postgraduate student training worldwide.</br> One of the indicators of the quality assurance of higher medical education is the need for schools providing medical education to have a unified evaluation method and to assess the level of knowledge, skills, and attitudes acquired by students. In order to objectively evaluate the student to improve the assessment of clinical skills, it is necessary to regularly evaluate the examination parameters. Thus, the evaluation of the clinical skills of the schools providing medical education needs to be accurate and objective, and it is necessary to develop a general evaluation model, so this study was selected for conducting.@*Goal@#Analyzing tasks in advanced skills tests@*Material and Methods@#In our research work, we used the numerical data of the students’ achievement presented to him by a total of n=113 clinical case assignments of the 6 stations of the 5th year advanced skills test of the School of Health of Etugen University.@*Research results@#Examining the reliability of the progress skills test with examinee performance at each of the 6 stations, reliability at the anamnesis station (KR=0.91) was a maximum score of 100, a minimum score of 16.5, and reliability at the actual examination station (KR=0.90) was a maximum score of 100, minimum score 40, reliability on diagnosis station (KR=0.93) maximum inter-examiner score 100, minimum score 61, reliability on manual action station (KR=0.88) maximum inter-examiner score 100, minimum score 64, reliability on treatment station (KR=0.85) The maximum score of the examinees was 100, the minimum score was 23, and the reliability of the counseling center (KR=0.90) was the maximum score of the examinees was 100, and the minimum score was 45.@*Conclusion@#</br>1. The reliability of the test is at a sufficient level without statistically significant differences in 6 stations. </br>2. The clinical case of each examination station differs in the degree of difficulty of the task: 30 percent (n=95) of the 20 tasks at the treatment station are very difficult, 33.0 percent (n=104) are difficult, 22.7 percent (n=87) are ideal, and 8.9 percent are ideal. (n=28) clinical cases with mild symptoms were evaluated. It is possible to set a threshold of 70 percent for passing the Advanced Skills Test.
ABSTRACT
Introduction@#Human beings have been using raw materials of plant and animal origin for the treatment of various diseases. Nowadays, in developed and developing countries, plant raw materials are widely used in traditional medicine, health care, and food supplements, and they are used as raw materials in pharmaceutical production, making up a large part of the world pharmaceutical market. Therefore, research activities are intensively carried out to determine the chemical composition and mineral content of plant-derived raw materials and explain the mechanism of action.@*Goal@#Allium polyrhizum Turcz.ex Regel determination of chemical compounds macro and micro elements and amino acids@*Material and Methods@#Allium polyrhizum Turcz.ex Regel was collected and prepared from Huvut shar Khoshun, Shili River Province, Institute of Mongolia medicine chemistry, Inner Mongolia university, Inner Mongolia Key Laboratory Medicine Chemistry. then it was made into a type with 0.075 mm particle size by a grinding machine. @*Result@#Dete-rmining the elemental composition of plant raw materials is important for determining the therapeutic value and safety of the plant. Some elements in Allium polyrhizum Turcz.ex Regel were determined by X-ray fluorescence method.@*Conclusions@#</br>1. In this study, the content of 7 elements in the above-ground part of Allium polyrhizum Turcz was determined using the XRF analysis method. Of the macro and micro elements such as Ca, K, Mn, Fe, Na, Zn, and Mg, which are essential for the human body, potassium (K) 49.7 mg/kg, calcium (Ca) 45.7 mg/kg, and sodium (Na) 31.0 mg/kg are the most had a high concentration. </br>2. Among various amino acids involved in protein synthesis, glutamic acid 1.89 mg, aspartic acid 1.48 mg, and alanine 1.00 mg were identified.
ABSTRACT
Introduction@#One of the world’s leading causes of mortality, WHO projects that diabetes will be the seventh leading cause of death in 2030. Therefore, there is absolutely need for prevention and treatment of diabetes, and scientists are keen to introduce a variety of drug and non-drug treatment methods.@*Goal@#To examine effect of Artemisia commutata Bess aqueous extract on Wistar rats with diabetes model type II induced by STZ with high fat diet.@*Material and Methods@#Experimental was performed in Institute of Mongolian medicine and Chemistry, Inner Mongolia University. In study, 32 Wistar rats (body weight 180-200 g, healthy) were divided into 4 groups included Normal, Model, Metformin and Artemisia commutata Bess. Type II diabetes were induced by intraperitoneal single dose STZ 56.25 mg/kg with high fat diet except for Normal group. Then Metformin group was received by oral administration at a dosage of 50 mg/kg/day and Artemisia commutata Bess group was received by oral administration at a dosage of 55 mg/kg/day during 30 days. Blood glucose (GLU), triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT) levels were tested at the end of the experiment. Pancreatic sections were stained with hematoxylin-eosin (HE).@*Results@#The level of blood glucose was significantly increased in Model group (23.9±1.33 mmo/L) compare to Normal group (5.64±0.24 mmol/L). Oral amdinistration of Artemisia commutata Bess 55 mg/kg/ day to treated group (9.75±1.84 mmol/L), Metformin 50 mg/kg/day to treated group (9.04±2.75 mmol/L) resulted in significantly decreased of blood glucose level less Model group.@*Conclusion@#This study demonstrated that hypoglycemic effect of Artemisia commutata Bess on diabetes model type II induced by STZ with high fat diet in Wistar rats.
ABSTRACT
Introduction: With the average longevity in men and women, sexual health concerns have become more and more important and demands for help are far more common than in the past. The percentage of aging population is increasing also. A metabolic and hormonal change occurs in male during aging.The level of total, free and bioavailable testosterone decline with aging and it leads to decrease in sexual activities, metabolism and also the life quality.The aim of this initial study was the determination of free testosterone and bioavailable testosterone and it was the novelty of our study. Data obtained from our research can be used as basic information for hormone replacement therapy in late onset hypogonadism.Research goal: To study the free testosterone and bioavailable testosterone level in aging malesMaterials and Methods: This study is a part of study: “Androgen status of aging males” which was supported by Asian Research Center, Korean Foundation for Advanced Studies. The study was approved by IRB of MoH and written consent was obtained from all participants.Fasting blood samples were collected in the morning between 8.00-10.00 AM. We used commercial ELISA kits from Magiwel CoLtd (USA) for determining the total testosterone, sex hormone binding globulin levels. Bromcresol green method was used in determination of serum albumin level. Bioavailable and free testosterone were calculated by Alex Vermeulen, Lieve Verdonk and M. Kaufman’s formula, which was recommended by International Society for the Study of Aging Male.We studied 114 healthy males aged above 40 years old, all undergone the General and Urological examination.Result and discussion: The average age was 57.48±10.48 years in our study participants. In group of 40-49 years were 29% (n=33), in 50-59 age group 23% (n=26), in 60-69 age group 27% (n=38) and in age group over 70-s were 15% (n=17).Mean total testosterone was 6.04±1.83 ng/ml, in 40-49 age group it was 6.14±1.65 ng/ml, in 50-59 age group 6.04±2.36 ng/ml, in 60-69 age group 6.05±1.80 ng/ml, and over 70’s it was 5.85±1.43 ng/ml.Mean sex hormone binding globulin was 50.22±29.97 nmol/l, in 40-49 age group 37.60±23.03 nmol/l, in 50-59 age group 47.08±29.61 nmol/l, in 60-69 age group 57.24±33.91 nmol/l, and over 70’s it was 59.22±25.38 nmol/l.Mean albumin was 40.86±6.89 g/l, in 40-49 age group 44.55±5.93 g/l, in 50-59 age group 41.85±6.93 g/l, in 60-69 age group 38.92±6.85 g/l, and over 70’s was 36.55±4.77 g/l.Mean free testosterone was 0.112±0.064 ng/ml, in 40- 49 age group 0.124±0.058 ng/ml, in 50-59 age group0.114±0.077 ng/ml, in 60-69 age group 0.107±0.072 ng/ml, and over 70’s it was 0.097±0.044 ng/ml.Mean bioavailable testosterone was 2.53±1.48 ng/ ml, in 40-49 age group 2.76±1.37 ng/ml, in 50-59 age group 2.60±1.70 ng/ml, in 60-69 age group 2.51±1.56 ng/ml, and over 70’s it was 2.04±1.05 ng/ml.Conclusion:1. In our participants aged above 40 years old, the average mean of free testosterone was 0.112±0.066 ng/ml, free testosterone index was 16.95±11.82. Free testosterone had inverse correlation with aging (r=-0.168, p=0.03) and had peer decline among aging groups.2. The average mean of bioavailable testosterone was 2.53±1.48 ng/ml, and had age related inverse correlation (r=-0.169, p=0.037), which decline was deeper in men aged over 70 years.Key words:Aging, total, free, bioavailable testosterone,free testosterone index
ABSTRACT
Background: Discrepancies in the sensitivity to biological effects of the androgens, exerted through the binding of the hormone to the androgen receptor (AR), may also be involved in the inter-individual variation of T as well as in age related decline. The human androgen receptor (AR), located on chromosome Xq11-12, is a transcription factor regulating the development of male reproductive organs in the fetus and secondary sex characteristics at puberty in response to testosterone (T) and 5a-dihydrotestosterone (DHT). The AR contains two polymorphic regions, the (CAG)nCAA repeat encoding polyglutamine, and the (GGT)3GGG(GGT)2(GGC)n repeat encoding polyglycine, commonly referred to as the CAG and GGN repeats respectively. The aim of this study is to investigate the effect of the human androgen receptor genes CAG and GGN repeat polymorphisms in relation with androgen level.Materials and Methods: Sample collection: 180 male, the medical data of these volunteers were obtained and determined some androgen hormones at first phase of study in 2010-2011 (total testosterone (TT), free testosterone (FT) and bioavailable testosterone (BAT)). To determine CAG/GGN repeats length in exon of androgen receptor gene, using frozen serum as a source of deoxyribonucleic acid (DNA). DNA was extracted from blood samples (200 ml) using High PurePCR Template Preparation Kits.Results: The 180 men whose age is at least 40 were involved in our research and their average age was 55.1±10.3. The 46.7% (84) of the participants presents CAG gene, the 6.1% (11) of the participants presents GGN gene while the 25.5% (46) of the participants presents both CAG and GGN genes. However, the 21.7% of 39 men not presents CAG and GGN genes.Conclusion: The free testosterone level was significantly decreasing with aging. However, the appearance of CAG gene polymorphism was significantly higher in more aged people. Decline of free testosterone level in participants with CAG and [CAG+GGN] combined form was stronger than in people with GGN gene polymorphism and CAG, GGN both undetected people. But the level of bioavailable testosterone was decreasing with aging and the appearance of CAG gene polymorphism (r=-0.425, p=0.01) and [CAG+GGN] combined form (r=-0.491, p=0.028) was also increasing.
ABSTRACT
Introduction: Erectile dysfunction (ED), also known as impotence, is defined as a consistent or recurrent inability to attain and/or maintain penile erection sufficient for sexual performance [1]. According to recent study results, ED occurs more than 50% over 60 year old males, emphasizing a need to diagnose and treat it at an earlier stage. ED may be assessed in several ways. The most widely used standardized questionnaire is the International Index of Erectile Function (IIEF) with 15 questions, which also exists in a short form with 5 questions [2]. On the other hand, ED is associated with a decreased level of androgens in aging males; the latter is often referred to as a Late Onset Hypogonadism (LOH) or Testosterone Deficiency Syndrome (TDS). In simple terms, LOH or TDS can be defined as a decreased serum testosterone level in aging males [3, 4]Objective: To detect the testosterone deficiency syndrome in aging males with erectile dysfunction. Materials and Methods. 309 males over 40 years of age who received medical care at the ADAM urological and andrological clinic from 2010 to 2011 were included in this study. An approval of the Ethical Committee of MOH was obtained at the commencement of the study. Each study participant signed a consent form at the beginning of the study. Each participant was assigned to either an ED group or a control group depending on results of the IIEF-5 questionnaire. The ED group was further divided into three groups (moderate, severe and very severe) based on a level of ED. The total testosterone (TT) levels were determined in blood serum, using a competitive ELISA analytical system UBI MAGIWELTM TestosteroneQuantitative test (GLS, USA), with C.V. (%) 6.8 and free testosterone (FT) calculated as described by Vermeulen. Test samples were collected between 8.00-11.00 am. The biochemical diagnosis of TDS was based on the Study Aging Male (ISSAM) guidelines of the International Society, particularly, if TT was _3.46 ng/ml or free testosterone FT was ≤0.072 ng/ml [5].Results: ED of moderate, severe and very severe levels were diagnosed in 199 (64.41%) out of 309 participants. There was an inverse association between an erectile function and age (r=-0.380, p <0.01). The average TT was 5.75±2.316 ng/ml and FT was 0.091±0.0084 ng/ml. Compared to the ED group, the control group had a higher TT level: 5.6440±1.177 ng/ml and 5.812±2.316 ng/ml respectively. In the control group the FT level was 0.061±0.0084 ng/ml whereas it was 0.041±0.0076 ng/ml in the ED group. Conclusion: Our study showed that most of aging males who came to the clinic had a moderate to very severe ED (64.55%). The level of TT (5.644±1.177 ng/ml) and FT (0.041±0.0036 ng/ml) was significantly lower in ED patients (p<0.05). The testosterone deficiency syndrome was detected in 24.27% of the ED group.
ABSTRACT
Materials and Methods: We studied 114 healthy males aged above 40 years old, who undergone urologists examination and General practitioner. All men answered the Aging Males’ Symptom Scale questionnaire. This is part of the ongoing study Mongolian males Andrological Status sponsored by Asian Research center, Korean Foundation for Advenced Studies. Formal concent permission was obtained from all participants, which approved by Ethical Committee of MoH. We took 4 ml blood from vien between 8-11am and determined testosterone, SHBG by ELISA and albumin by liquicolor reagent. Bioavailable testosterone was calculated, using previously described mathematical modeling, suggested by ISSAM.Result: The average free testosterone level was 0.112±0.06 ng/ml, in 40-49 age group 0.124±0.05 ng/ml, in 50-59 age group 0.114±0.07 ng/ml, in 60-69 age group 0.107±0.07 ng/ml, and over 70’s it was 0.097±0.04 ng/ml. If consider the free testosterone 100%, in 40-49 age than it is decreasing 91.6% in 50-59, 83.3% in 60-69 ages and 75% decreased in over 70s. Respectively, it decreases approximately by 0.8% every year after 40’s.Conclusion: The free testosterone level was 0.11±0.06 ng/ml in aging males and has reverse correlation with aging (r=-0.168, p= 0.03).
ABSTRACT
Introduction: With the increasing longevity in men and women, sexual health concerns have become more and more important and demands for help are far more common than in the past. The percentage of aging population is increasing also. The of this study in aging men. Late onset hypogonadism will need the testosterone replacement therapy and we hope that our study result will help to get basic information of testosterone among over 40 yearsold Mongolian men.Goal: To determine the bioavailable testosterone (BT) of aging males and correlate with aging process.Materials and Methods: This study is a part of ongoing study: “Androgen status of aging males” which was supported by Asian Research Center, Korean Foundation for Advanced Studies. We studied 114 healthy males aged above 40 years old, all undergone the General and Urological examination. Bioavailable testosterone was determined by formula suggested by ISSAM.Result: The average bioavailable testosterone level was 2.53±1.48 ng/ml, in 40-49 age group 2.76±1.37 ng/ml, in 50-59 age group 2.60±1.70 ng/ml, in 60-69 age group 2.51±1.56 ng/ml, and over 70’s it was 2.04±1.05 ng/ml. If consider the bioavailable testosterone 100%, in 40-49 age than it is decreasing 94.2% in 50-59, 90.9% in 60-69 ages and 73.9% decreased in over 70s. Respectively, it decreases approximately by 0.9% every year after 40’s.Conclusion: The bioavailable testosterone level was 2.53±1.48ng/ml in aging males and has reverse correlation with aging (r=-0.169, p=0.037).